ArticleOncology research2017

Three Combined Treatments, a Novel HDAC Inhibitor OBP-801/YM753, 5-Fluorouracil, and Paclitaxel, Induce G₂ Phase Arrest Through the p38 Pathway in Human Ovarian Cancer Cells.

Makoto Akiyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.